Wells Fargo analyst John Kilichowski maintained a Buy rating on Agree Realty (ADC – Research Report) today and set a price target of $81.00. The company’s shares closed last Friday at $76.02.

Beyond novel ADC designs, it is notable that novel ADC use cases in domains beyond conventional oncology, including autoimmune conditions, infectious conditions, and other chronic conditions ...

Smite 2's Open Beta 4 update introduces the goddess Artemis, along with Cross-Gen and Classic skins. A new cosmetic, Thor Thunderstruck, has also been added in this February update. The patch also ...

TAIPEI, Taiwan, March 12, 2025 (GLOBE NEWSWIRE) -- At the ADC Asia Congress 2025 held today (3/12) in Singapore, OBI Pharma (4174.TWO) was honored with the "Most Promising ADC Clinical Candidate ...

The U.S. biotech is paying (PDF) China’s CSPC Megalith Biopharmaceutical $15 million upfront for rights to an antibody-drug conjugate (ADC), securing itself a shot at challenging Merck & Co. for ...

The ODT-ADS-7B64G-3 is an ultra-high-bandwidth time-interleaved ADC designed in a 3nm CMOS process. This 7-bit, 64GSPS ADC supports ac-coupled input signals up to Nyquist and features a full-scale ...

Meghan Markle recently unveiled her rebranded lifestyle brand, As Ever, and its new logo is packed with subtle nods to her family and personal history. The design features a palm tree encased by ...

The landing page revealed the As Ever logo, which PEOPLE understands is a tribute to Prince Harry. The logo incorporates a palm tree as a nod to the Duke and Duchess’s home in California ...

When is the Smite 2 1.0 release date? Following some confusion around the Smite sequel thanks to a closed alpha period in May 2024 and an incorrect release date on Steam, the official free-to-play ...

Meghan's forthcoming lifestyle brand, As Ever, replaces American Riviera Orchard, and its logo features some symbolic details – one of which could be a tribute to Prince Harry's late grandmother ...

The phase 1b trial is investigating the ADC and Keytruda – with or without chemo – in both previously-untreated and pretreated patients with advanced NSCLC who don’t have genetic mutations ...

The FDA thinks an antibody-drug conjugate (ADC) developed by AbbVie could set new standards in treatment for certain patients with lung cancer, awarding the drug breakthrough status. Teliso-V ...